Advertisement
Home Blog Page 3567
Portrazza (necitumumab)

FDA Approves Portrazza for Advanced Squamous NSCLC

0
Drug is designed to block activity of epidermal growth factor receptor protein
Nearly half of Medicaid patients with chronic hepatitis C have been denied newer direct-acting antiviral medications

Expensive Hep C Drugs Denied to Almost Half of Medicaid Patients

0
Most common reason for denial was "insufficient information to assess medical need"
More early-stage cervical cancers have been diagnosed among young U.S. women since a key provision of the Affordable Care Act went into effect

Early-Stage Cervical CA Diagnoses in Young Women Up Since ACA

0
Provision allowing young adults to stay on parents' insurance may account for more screening
For older adults

No Direct Survival Effect for Moderate Drinking in Seniors

0
Significant correlation for seniors does not persist after adjustment for health status, physical activity
Intraplaque hemorrhage is prevalent in 23.3 percent of asymptomatic patients with type 2 diabetes

RSNA: Intraplaque Hemorrhage Prevalent in Type 2 Diabetes

0
IPH seen in 23.3 percent of patients; vessel wall volume significantly different in IPH positive vessels
For women with early-stage breast cancer

Impact of Recurrence Score Assay Varies With Patient Age

0
For women with early-stage breast cancer, testing lowers chemo use, costs among women <55 years
For women with a history of gestational diabetes mellitus

Animal-Source, Low-Carb Diet Ups T2DM Risk With Past GDM

0
Increased risk of T2DM for overall low-carbohydrate diet scores and animal LCD scores
Both retinol and retinoic acid have beneficial effects on cellular and molecular properties of the epidermis and dermis

Topical Retinol Induces Skin Changes Similar to Retinoic Acid

0
Retinoic acid, retinol treatments both increase epidermal thickness, up gene, protein expression
Infant deaths linked to crib bumpers have spiked in recent years in the United States

Crib Bumpers Tied to Increasing Number of Infant Fatalities

0
Researchers strongly suggest banning the crib accessories
Opdivo (nivolumab) has been approved by the U.S. Food and Drug Administration to treat advanced renal cell carcinoma.

FDA Approves Opdivo for Advanced Renal Cell Carcinoma

0
Drug works by targeting the PD-1/PD-L1 cellular pathway